Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objectives of this post marketing surveillance study were to document the comorbidity and
comedication during prescription of ALNA® (Tamsulosin) for patients with BPH (Benign
Prostatic Hyperplasia).